Microbot Medical Inc. (MBOT)

Last Closing Price: 2.46 (2025-12-04)

Company Description

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-11.44M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.14
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -37.06%
Return on Assets (Trailing 12 Months) -34.44%
Current Ratio (Most Recent Fiscal Quarter) 27.53
Quick Ratio (Most Recent Fiscal Quarter) 27.53
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.17
Earnings per Share (Most Recent Fiscal Quarter) $-0.07
Earnings per Share (Most Recent Fiscal Year) $-0.73
Diluted Earnings per Share (Trailing 12 Months) $-0.45
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 67.16M
Free Float 63.98M
Market Capitalization $167.22M
Average Volume (Last 20 Days) 2.73M
Beta (Past 60 Months) 1.17
Percentage Held By Insiders (Latest Annual Proxy Report) 4.74%
Percentage Held By Institutions (Latest 13F Reports) 16.30%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%